Page 27 - Vaccination

Over 56.81 crore Covid vaccine doses provided to states, UTs: Govt

More than 56.81 crore COVID-19 vaccine doses have been provided to states and Union Territories so far through all sources, the Union health ministry said on Monday

Wayanad completes first dose vaccination of all above 18 years of age

Wayanad has become the first district in Kerala to complete the administration of the first dose of vaccine to all above the age of 18 years. State Health Minister Veena George on Monday appreciated the efforts of the health workers who were involved in the inoculation process of the targeted population above 18 years of age in the district. "The Wayanad district of Kerala has completed the first dose vaccine among all the eligible population above the age of 18 years. The specialty of Wayanad district is that it has got a more tribal population and I do appreciate all health workers who were involved in the vaccination process and are still engaged in the process in the best possible way," George told PTI. The achievement comes ahead of the visit of Union Health Minister Mansukh Mandaviya on Monday to review the COVID-19 situation in the southern state. The minister said that special mobile teams visited the tribal hamlets to administer the vaccine. "The government had formed 28

India records 36,083 new coronavirus cases, 493 deaths: Health ministry

India saw a single-day rise of 36,083 new coronavirus infections, raising its tally to 3,21,92,576, while the death toll has climbed to 4,31,225 with 493 fresh fatalities, according to health Ministry

All 1.8 mn eligible beneficiaries in Indore given first dose of vaccine

All eligible Covid-19 vaccine beneficiaries in Indore city in Madhya Pradesh have been administered the first dose, officials said on Friday.

Serum chairman Cyrus Poonawalla against using cocktail of Covid vaccines

Serum Institute of India (SII) chairman Dr Cyrus Poonawalla on Friday said he was not in favour of administering two different coronavirus vaccines for better efficacy. Poonawalla, whose firm makes the Covishield vaccine, was speaking to reporters after receiving the Lokmanya Tilak National Award here. "I am against the mixing of two different vaccines. There is no need to mix two different vaccines," he said, when asked about a recent ICMR study that a cocktail of Covishield and Covaxin could generate better immunity. "If cocktail vaccines are administered and if the result is not good, then SII may say that another vaccine was not good, vice versa, the other company might say that since you mixed Serum's vaccine, it did not give desired results," Poonawalla said. The efficacy of this approach has not been proven in field trials involving thousands of participants, he added. A study by the Indian Council of Medical Research involving 98 people, 18 of whom had inadvertently ...

Sri Lanka to make Covid-19 vaccine certificates mandatory from Sept 15

Sri Lanka on Friday announced that citizens from September 15 would require vaccination cards, to travel between provinces and in public spaces

Second Covid wave not over, daily cases still above 40,000: AIIMS chief

'It is important for everyone to follow Covid-appropriate behaviour. If we follow this, then another wave will not come,' says Randeep Guleria

Pregnant women to get Covid vaccine at their check-up facilities in Delhi

Pregnant and lactating women will be able to get vaccinated against COVID-19 at the clinics where they go for their ante-natal and post-natal check-ups, Delhi govt's official order said

US FDA okays Covid booster dose for those with weak immune system

The US FDA authorised both the Pfizer-BioNTech and Moderna's Covid-19 vaccine to administer an additional dose in people with weaker immune systems, which includes organ transplant recipients

NCW asks states to take measures to bridge gender gap in Covid vaccination

Raising concerns over gender gap in COVID-19 vaccine administration, the NCW has written to all states and UTs to take measures to ensure that women are not left behind in the vaccination drive

New Covid vaccine mimics virus shape to provide robust protection: Study

Scientists have developed a protein-based COVID-19 vaccine candidate that mimics the shape of the virus to trigger robust antibody response in animals

Decoded: Understanding the debate over coronavirus booster shots

US Centers for Disease Control and Prevention recommends that ad­ults receive boosters of the tetanus vaccine every dec­a­de

Mandaviya meets WHO chief scientist, discusses health body nod for Covaxin

Mandaviya on Thursday met WHO Chief Scientist Dr Soumya Swaminathan and held discussions over the global health body's approval for Bharat Biotech's COVID-19 vaccine Covaxin

Covid-19 infection linked to problems in thinking, attention: Study

People who have recovered from COVID-19 may face problems in cognitive tasks such as thinking and attention, according to a study of over 80,000 individuals

Majority Indians feel confident of preparedness for 3rd Covid wave: Survey

As many as 58 per cent of citizens surveyed feel confident that India is well prepared to handle the third wave of COVID, LocalCircles said on Thursday

Covid-19 may become a mostly childhood disease in few years: Study

Covid-19 may behave like other common-cold coronaviruses in the next few years, affecting mostly young children who have not yet been vaccinated or exposed to the virus, according to the study

RDIF proposes Pfizer conduct joint trial with Sputnik Light as booster shot

The Russian Direct Investment Fund (RDIF) has proposed that US drugmaker Pfizer start joint trials with Sputnik Light as a booster COVID-19 vaccine shot, the RDIF said on Wednesday."Delta cases surge in US & Israel shows mRNA vaccines need a heterogeneous booster to strengthen & prolong immune response. #SputnikV pioneered mix & match approach, combo trials & showed 83.1% efficacy vs Delta. Today RDIF offers Pfizer to start trial with Sputnik Light as booster," it said in a Tweet.It further said that Sputnik V is the first in the world to offer combo trial to AstraZeneca in November 2020, co-sponsored mix & match trials with AstraZeneca, Moderna and Sinopharm."Sputnik V was the 1st in the world to offer combo trial to AstraZeneca in Nov 2020, co-sponsored mix & match trials with AstraZeneca, Moderna & Sinopharm. Since then heterogeneous boosting pioneered by Sputnik proved to be effective vs mutations," it added further.According to an official ...

Availability of foreign Covid vaccines to get delayed over indemnity issue

India is not keen to grant indemnity to some players as it expects local availability to improve

Mumbai local trains: Issuing of monthly railway passes begins from tomorrow

An offline verification procedure for vaccination and issuing monthly passes to fully inoculated people to enable them to board local trains will start at 53 suburban stations in Mumbai

Over 300,000 pregnant women given first dose of Covid-vaccine: Govt

As many as 3,05,938 COVID-19 vaccine doses have been administered to pregnant women till August 4, the Rajya Sabha was told on Tuesday